Implementing the Epidemic Diseases Act to combat Covid-19 in India: An ethical analysis.
Indian J Med Ethics
; VI(1): 1-10, 2021.
Article
in English
| MEDLINE | ID: covidwho-1257361
ABSTRACT
Many states in India have invoked the provisions of the Epidemic Diseases Act, 1897, as a major tool in the fight against the Covid-19 pandemic. The current review attempts to discuss the ethical challenges in implementation of the Epidemic Diseases Act, 1897, to combat Covid-19 in India. Implementation of the Act in India has exposed its major limitations. It remains merely as a "policing" Act with no emphasis on coordinated and scientific responses to outbreaks and without provisions for protecting the rights of citizens. The Epidemic Diseases Act in its current form has the potential to cause more harm than good. Furthermore, the Epidemic Disease (Amendment) Bill, 2020, has not addressed any of these concerns. There is need for a rights-based, people-focused and public health-oriented law in India to deal with epidemics.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Public Health
/
Disease Outbreaks
/
Pandemics
/
COVID-19
Type of study:
Observational study
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Med Ethics
Journal subject:
Ethics
Year:
2021
Document Type:
Article
Affiliation country:
IJME.2020.129
Similar
MEDLINE
...
LILACS
LIS